IPM registers growth of 9.3 per cent in April 2013, valued at Rs 6239 crores
From therapeutic perspective, 10 therapies have outgrown the IPM story
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
IPA to organise 6th Symposium on Nasal and Pulmonary Drug Delivery
Symposium will be held in Mumbai on October 24 and 25, 2013
P-MEC India to showcase pharmaceutical machinery and equipment
Event to be held in Mumbai from December 3 to 5, 2013
PHARMA Pro&Pack Expo 2013 creates global benchmark of Brand India for pharma industry
Event organised by IPMMA and GPE Expo
Trial(s) by Fire
The Indian clinical trial industry is going through a tough time. Once slated to be the world's favourite destination for…
Venus signs marketing agreement with Korean Goodwills
Elores to fight `superbugs’ wins patent from South Korea
Aurobindo gets US FDA nod
Aurobindo Pharma has received final approvals from the US Food and Drug Administration (US FDA) to manufacture and market…
SeQuent obtains US FDA approval for API facility at Mangalore
The facility is ISO 9001 certified for Quality Management systems and ISO 14000 certified for Environment Management systems
M&A activity focuses on broadening product pipelines in selected specialty markets
The Indian pharma sector witnessed no deals during April 2013
Pharmac India 2013 to focus on pharma machinery, packaging and bulk drugs
Event to be held in Hyderabad from September 5-7
iPHEX 2013 pharma exhibition records over Rs 1000 crore profit
Over 5,000 trade visitors including overseas buyers, delegates from highly regulated markets like US, Europe, Australia and New…
6th international conference of SAC ACCP seeks active research to provide better healthcare delivery
Conducts workshops on outcomes research, pharmacovigilance PKPD, antibiotics stewardship and statistics
SPDS organises 1st international convention on dissolution in Mumbai
Disso India 2013 was attended by more than 300 delegates
NIRRH ICMR workshop enhances capacity for pharmacovigilance study
Programme consists of two contact sessions and one project work
Access to medicines: Beyond 2Ps
While price and patents have for long been considered as the two barriers impeding access to medicines, the issue extends far…
‘Manufacturers should engage the USFDA early during drug approval for naming of a…
United States Pharmacopeia's new monograph naming policy is all set to come into effect by May this year. Srini Srinivasan,…
Orchid enters strategic partnership with Allecra Therapeutics
Company’s will assign IP pertaining to a lead antibiotic compound